Zobrazeno 1 - 10
of 10 148
pro vyhledávání: '"Sahai E"'
Autor:
Boire A; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Burke K; University College London Hospitals NHS Foundation Trust and Central and North West London NHS Foundation Trust Palliative Care Team, London, UK., Cox TR; Cancer Ecosystems Program, The Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia. t.cox@garvan.org.au.; School of Clinical Medicine, St Vincent's Healthcare Clinical Campus, UNSW Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia. t.cox@garvan.org.au., Guise T; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jamal-Hanjani M; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK.; Cancer Research UK Lung Centre of Excellence, University College London Cancer Institute, London, UK., Janowitz T; Cold Spring Harbour Laboratory, Cold Spring Harbour, New York, NY, USA.; Northwell Health Cancer Institute, New York, NY, USA., Kaplan R; Paediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lee R; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Swanton C; Department of Oncology, University College London Hospitals, London, UK.; Cancer Research UK Lung Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Vander Heiden MG; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Sahai E; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK. erik.sahai@crick.ac.uk.
Publikováno v:
Nature reviews. Cancer [Nat Rev Cancer] 2024 Aug; Vol. 24 (8), pp. 578-589. Date of Electronic Publication: 2024 Jun 19.
Autor:
Magness A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. alastair.magness@crick.ac.uk., Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Enfield KSS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Lee C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Shimato M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Daly E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Moore DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Sivakumar M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Valand K; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Levi D; Flow Cytometry, The Francis Crick Institute, London, UK., Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hobson PS; Flow Cytometry, The Francis Crick Institute, London, UK., van Maldegem F; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUMC, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands., Reading JL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Pre-cancer Immunology Laboratory, University College London Cancer Institute, London, UK.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research, Department of Haematology, University College London Cancer Institute, London, UK., Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research, Department of Haematology, University College London Cancer Institute, London, UK., Downward J; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Sahai E; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk., Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. mihaela.angelova@crick.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2024 Jun 15; Vol. 15 (1), pp. 5135. Date of Electronic Publication: 2024 Jun 15.
Autor:
Enfield KSS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Lee C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Magness A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Moore DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Department of Cellular Pathology, University College London Hospitals, London, United Kingdom., Sivakumar M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom., Grigoriadis K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Karasaki T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, United Kingdom., Hobson PS; Flow Cytometry, The Francis Crick Institute, London, United Kingdom., Levi D; Flow Cytometry, The Francis Crick Institute, London, United Kingdom., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom., Puttick C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom., Nye EL; Experimental Histopathology, The Francis Crick Institute, London, United Kingdom., Green M; Experimental Histopathology, The Francis Crick Institute, London, United Kingdom., Dijkstra KK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Shimato M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom., Akarca AU; Department of Cellular Pathology, University College London Hospitals, London, United Kingdom., Marafioti T; Department of Cellular Pathology, University College London Hospitals, London, United Kingdom., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia., Hackshaw A; Cancer Research UK and University College London Cancer Trials Centre, London, United Kingdom., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, United Kingdom.; Department of Oncology, University College London Hospitals, London, United Kingdom., van Maldegem F; Oncogene Biology Laboratory, The Francis Crick Institute, London, United Kingdom., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom., Glass B; PathAI, Inc., Boston, Massachusetts., Pulaski H; PathAI, Inc., Boston, Massachusetts., Walk E; PathAI, Inc., Boston, Massachusetts., Reading JL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Pre-cancer Immunology Laboratory, University College London Cancer Institute, London, United Kingdom.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, United Kingdom., Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, United Kingdom., Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom., Downward J; Oncogene Biology Laboratory, The Francis Crick Institute, London, United Kingdom., Sahai E; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, United Kingdom., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Department of Oncology, University College London Hospitals, London, United Kingdom., Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Jun 03; Vol. 14 (6), pp. 1018-1047.
Autor:
Ishibashi K; Division of Tumor Cell Biology and Bioimaging, Cancer Research Institute of Kanazawa University, Kanazawa 920-1192, Ishikawa, Japan., Ichinose T; Department of Neurosurgery, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-8641, Ishikawa, Japan., Kadokawa R; Division of Tumor Cell Biology and Bioimaging, Cancer Research Institute of Kanazawa University, Kanazawa 920-1192, Ishikawa, Japan., Mizutani R; Division of Tumor Cell Biology and Bioimaging, Cancer Research Institute of Kanazawa University, Kanazawa 920-1192, Ishikawa, Japan., Iwabuchi S; Department of Molecular Pathophysiology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama 641-8509, Wakayama, Japan., Togi S; Center for Clinical Genomics, Kanazawa Medical University Hospital, Uchinada 920-0293, Ishikawa, Japan; Division of Genomic Medicine, Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan., Ura H; Center for Clinical Genomics, Kanazawa Medical University Hospital, Uchinada 920-0293, Ishikawa, Japan; Division of Genomic Medicine, Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan., Tange S; Department of Medical Genome Sciences, Cancer Research Institute, Sapporo Medical University School of Medicine, Sapporo 060-8556, Hokkaido, Japan., Shinjo K; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Aichi, Japan., Nakayama J; Department of Oncogenesis and Growth Regulation, Research Institute, Osaka International Cancer Institute, Osaka 541-8567, Osaka, Japan., Nanjo S; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa 920-8641, Ishikawa, Japan; Division of Medical Oncology, Cancer Research Institute of Kanazawa University, Kanazawa 920-8641, Ishikawa, Japan., Niida Y; Center for Clinical Genomics, Kanazawa Medical University Hospital, Uchinada 920-0293, Ishikawa, Japan; Division of Genomic Medicine, Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan., Kondo Y; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Aichi, Japan., Hashimoto S; Department of Molecular Pathophysiology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama 641-8509, Wakayama, Japan., Sahai E; Tumor Cell Biology Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Yano S; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa 920-8641, Ishikawa, Japan; Division of Medical Oncology, Cancer Research Institute of Kanazawa University, Kanazawa 920-8641, Ishikawa, Japan; Nano Life Science Institute, Kanazawa University, Kanazawa 920-1192, Ishikawa, Japan., Nakada M; Department of Neurosurgery, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-8641, Ishikawa, Japan., Hirata E; Division of Tumor Cell Biology and Bioimaging, Cancer Research Institute of Kanazawa University, Kanazawa 920-1192, Ishikawa, Japan; Nano Life Science Institute, Kanazawa University, Kanazawa 920-1192, Ishikawa, Japan. Electronic address: ehirata@staff.kanazawa-u.ac.jp.
Publikováno v:
Developmental cell [Dev Cell] 2024 Mar 11; Vol. 59 (5), pp. 579-594.e6. Date of Electronic Publication: 2024 Feb 02.
Publikováno v:
Developmental cell [Dev Cell] 2023 Dec 18; Vol. 58 (24), pp. 2819-2821.
Autor:
Whisler J; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Shahreza S; Department of Mechanical Engineering, University College London, London, UK., Schlegelmilch K; Tumour Cell Biology Laboratory, Francis Crick Institute, London, UK., Ege N; Tumour Cell Biology Laboratory, Francis Crick Institute, London, UK.; Mnemo Therapeutics, 101 Boulevard Murat, 75016 Paris, France., Javanmardi Y; Department of Mechanical Engineering, University College London, London, UK., Malandrino A; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Biomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Engineering and Research Center for Biomedical Engineering, Universitat Politècnica de Catalunya (UPC), Av. Eduard Maristany, 10-14 08019 Barcelona, Spain., Agrawal A; Department of Mechanical Engineering, University College London, London, UK., Fantin A; UCL Institute of Ophthalmology, University College London, London, UK.; Department of Biosciences, University of Milan, Via G. Celoria 26, 20133 Milan, Italy., Serwinski B; Department of Mechanical Engineering, University College London, London, UK.; 199 Biotechnologies Ltd., Gloucester Road, London W2 6LD, UK.; Northeastern University London, London, E1W 1LP, UK., Azizgolshani H; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Park C; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Shone V; Experimental Histopathology Laboratory, Francis Crick Institute, London, UK., Demuren OO; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Del Rosario A; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Butty VL; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Holroyd N; UCL Centre for Advanced Biomedical Imaging, Paul O'Gorman Building, 72 Huntley Street, London, UK., Domart MC; Electron Microscopy Laboratory, Francis Crick Institute, London, UK., Hooper S; Tumour Cell Biology Laboratory, Francis Crick Institute, London, UK., Szita N; Department of Biochemical Engineering, University College London, London, UK., Boyer LA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Walker-Samuel S; UCL Centre for Advanced Biomedical Imaging, Paul O'Gorman Building, 72 Huntley Street, London, UK., Djordjevic B; Department of Mechanical Engineering, University College London, London, UK.; 199 Biotechnologies Ltd., Gloucester Road, London W2 6LD, UK., Sheridan GK; School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK., Collinson L; Electron Microscopy Laboratory, Francis Crick Institute, London, UK., Calvo F; Instituto de Biomedicina y Biotecnología de Cantabria (Consejo Superior de Investigaciones Científicas, Universidad de Cantabria), Santander, Spain., Ruhrberg C; UCL Institute of Ophthalmology, University College London, London, UK., Sahai E; Tumour Cell Biology Laboratory, Francis Crick Institute, London, UK., Kamm R; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Moeendarbary E; Department of Mechanical Engineering, University College London, London, UK.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; 199 Biotechnologies Ltd., Gloucester Road, London W2 6LD, UK.
Publikováno v:
Science advances [Sci Adv] 2023 Aug 11; Vol. 9 (32), pp. eadg9781. Date of Electronic Publication: 2023 Aug 11.
Autor:
Fu X; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK.; Biomolecular Modelling Laboratory, The Francis Crick Institute, London, UK., Sahai E; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., Wilkins A; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK.; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK.; Royal Marsden Hospitals NHS Trust, London, UK.
Publikováno v:
The Journal of pathology [J Pathol] 2023 Aug; Vol. 260 (5), pp. 578-591. Date of Electronic Publication: 2023 Aug 08.
Autor:
Hu J; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden., Serra-Picamal X; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden., Bakker GJ; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Van Troys M; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium., Winograd-Katz S; Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel., Ege N; The Francis Crick Institute, London, UK., Gong X; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden., Didan Y; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden., Grosheva I; Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel., Polansky O; Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel., Bakkali K; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium., Van Hamme E; Bio Imaging Core, VIB Center for Inflammation Research, Ghent, Belgium., van Erp M; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Vullings M; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Weiss F; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Clucas J; The Francis Crick Institute, London, UK., Dowbaj AM; The Francis Crick Institute, London, UK., Sahai E; The Francis Crick Institute, London, UK., Ampe C; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium., Geiger B; Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel., Friedl P; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Bottai M; Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Strömblad S; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
Molecular systems biology [Mol Syst Biol] 2023 Jun 12; Vol. 19 (6), pp. e11490. Date of Electronic Publication: 2023 Apr 17.
Autor:
Pinner, S.1 Sophie.Pinner@cancer.org.uk, Sahai, E.1
Publikováno v:
Journal of Microscopy. Sep2008, Vol. 231 Issue 3, p441-445. 5p. 1 Color Photograph, 1 Diagram.
Autor:
Kato T; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, United Kingdom.; Department of Pathology, Kitasato University, Sagamihara, Japan., Jenkins RP; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, United Kingdom., Derzsi S; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, United Kingdom.; Hoffman La-Roche, Basel, Switzerland., Tozluoglu M; Biomolecular Modelling Laboratory, The Francis Crick Institute, London, United Kingdom., Rullan A; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, United Kingdom.; Institute of Cancer Research, London, United Kingdom., Hooper S; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, United Kingdom., Chaleil RAG; Biomolecular Modelling Laboratory, The Francis Crick Institute, London, United Kingdom., Joyce H; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, United Kingdom., Fu X; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, United Kingdom.; Biomolecular Modelling Laboratory, The Francis Crick Institute, London, United Kingdom., Thavaraj S; Centre for Oral, Clinical and Translational Sciences, King's College London, London, United Kingdom., Bates PA; Biomolecular Modelling Laboratory, The Francis Crick Institute, London, United Kingdom., Sahai E; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, United Kingdom.
Publikováno v:
ELife [Elife] 2023 Mar 09; Vol. 12. Date of Electronic Publication: 2023 Mar 09.